UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Retraction Note: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

Scientific reports, 2024-05, Vol.14 (1), p.9989-9989, Article 9989

2024

Volltextzugriff (PDF)

Transfusion-associated hepatitis E, France

Emerging infectious diseases, 2007-04, Vol.13 (4), p.648-649

2007

Volltextzugriff (PDF)

Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

Scientific reports, 2020-12, Vol.10 (1)

2020

Volltextzugriff (PDF)

Publisher Correction: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

Scientific reports, 2020-09, Vol.10 (1), p.14829-14829, Article 14829

2020

Volltextzugriff (PDF)

Prevalent, persistent anal HPV infection and squamous intraepithelial lesions: Findings from a cohort of men living with HIV in South Africa

PloS one, 2019-12, Vol.14 (12), p.e0225571-e0225571

2019

Volltextzugriff (PDF)

HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study

PloS one, 2012-12, Vol.7 (12), p.e53035-e53035

2012

Volltextzugriff (PDF)

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France

AIDS (London), 2009-03, Vol.23 (6), p.717-724

2009

Volltextzugriff (PDF)

Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

Infectious disorders drug targets, 2012-02, Vol.12 (1), p.81-86

2012

Volltextzugriff (PDF)

Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers

Virology (New York, N.Y.), 2007-10, Vol.367 (1), p.30-40

2007

Volltextzugriff (PDF)

Hepatitis B and E Co-Primary Infections in an HIV-1-Infected Patient

Journal of Clinical Microbiology, 2013-03, Vol.51 (3), p.1052-1056

2013

Volltextzugriff (PDF)

Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

Antimicrobial Agents and Chemotherapy, 2010-08, Vol.54 (8), p.3335-3340

2010

Volltextzugriff (PDF)

Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient

Journal of clinical virology, 2013-09, Vol.58 (1), p.309-314

2013

Volltextzugriff (PDF)

Entecavir as a first‐line treatment for HBV reactivation following polychemotherapy for lymphoma

British journal of haematology, 2008-10, Vol.143 (1), p.148-150

2008

Volltextzugriff (PDF)

Detection of the newly characterized HIV CRF56_cpx in Marseille, southeastern France

International journal of infectious diseases, 2014-12, Vol.29 (C), p.241-243

2014

Volltextzugriff (PDF)

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment‐naïve chronically infected patient

Hepatology (Baltimore, Md.), 2008-02, Vol.47 (2), p.766-767

2008

Volltextzugriff (PDF)

A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer

Retrovirology, 2012-05, Vol.9 (S1), p.P66-P66, Article P66

2012

Volltextzugriff (PDF)

Detection of a newly identified hepatitis B virus genotype in southeastern France

Journal of clinical virology, 2009-06, Vol.45 (2), p.165-167

2009

Volltextzugriff (PDF)

SVARAP and aSVARAP: simple tools for quantitative analysis of nucleotide and amino acid variability and primer selection for clinical microbiology

BMC microbiology, 2006-03, Vol.6 (1), p.21-21, Article 21

2006

Volltextzugriff (PDF)

Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients

Antimicrobial Agents and Chemotherapy, 2010-01, Vol.54 (1), p.72-77

2010

Volltextzugriff (PDF)

Misuse of PrEP and atypical HIV seroconversion: about a case

Journal of Virus Eradication, 2018-05, Vol.4, p.23

2018

Volltextzugriff (PDF)

Resistance to human immunodeficiency virus infection: a rare but neglected state

Annals of the New York Academy of Sciences, 2021-02, Vol.1485 (1), p.22-42

2021

Volltextzugriff (PDF)

Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences

Journal of Clinical Microbiology, 1999-12, Vol.37 (12), p.4099-4106

1999

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(186)
Berichte
(10)

Sprache

Englisch
(192)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Retraction Note: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

Transfusion-associated hepatitis E, France

Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

Publisher Correction: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

Prevalent, persistent anal HPV infection and squamous intraepithelial lesions: Findings from a cohort of men living with HIV in South Africa

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France

Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers

Hepatitis B and E Co-Primary Infections in an HIV-1-Infected Patient

Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient

Entecavir as a first‐line treatment for HBV reactivation following polychemotherapy for lymphoma

Correction: HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 “Aging” Study

Detection of the newly characterized HIV CRF56_cpx in Marseille, southeastern France

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment‐naïve chronically infected patient

A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer

HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study

Detection of a newly identified hepatitis B virus genotype in southeastern France

SVARAP and aSVARAP: simple tools for quantitative analysis of nucleotide and amino acid variability and primer selection for clinical microbiology

Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients

Misuse of PrEP and atypical HIV seroconversion: about a case

Resistance to human immunodeficiency virus infection: a rare but neglected state

Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences

Suchergebnisse filtern